{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:47:17Z","timestamp":1791247637904,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T00:00:00Z","timestamp":1351468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T00:00:00Z","timestamp":1351468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1038\/aps.2012.150","type":"journal-article","created":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T13:19:09Z","timestamp":1351516749000},"page":"176-184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Galectin-3 gene silencing inhibits migration and invasion of human tongue cancer cells in vitro via downregulating \u03b2-catenin"],"prefix":"10.1038","volume":"34","author":[{"given":"Dong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuo-qing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Dalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-san","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-wei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-cai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,29]]},"reference":[{"key":"BFaps2012150_CR1","doi-asserted-by":"publisher","first-page":"412908","DOI":"10.1155\/2009\/412908","volume":"2009","author":"D Ferrari","year":"2009","unstructured":"Ferrari D, Codeca C, Fiore J, Moneqhini L, Bosari S, Foa P . Biomolecular markers in cancer of the tongue. J Oncol 2009; 2009: 412908.","journal-title":"J Oncol"},{"key":"BFaps2012150_CR2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10555-007-9082-y","volume":"26","author":"D Sano","year":"2007","unstructured":"Sano D, Myers JN . Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev 2007; 26: 645\u201362.","journal-title":"Cancer Metastasis Rev"},{"key":"BFaps2012150_CR3","first-page":"983","volume":"25","author":"S Califice","year":"2004","unstructured":"Califice S, Castronovo V, Van Den Brule F . Galectin-3 and cancer. Int J Oncol 2004; 25: 983\u201392.","journal-title":"Int J Oncol"},{"key":"BFaps2012150_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10863-006-9063-9","volume":"39","author":"P Nangia-Makker","year":"2007","unstructured":"Nangia-Makker P, Nakahara S, Hogan V, Raz A . Galectin-3 in apoptosis, a novel therapeutic target. J Bioenerg Biomembr 2007; 39: 79\u201384.","journal-title":"J Bioenerg Biomembr"},{"key":"BFaps2012150_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10585-011-9376-x","volume":"28","author":"T Kobayashi","year":"2011","unstructured":"Kobayashi T, Shimura T, Yajima T, Kubo N, Araki K, Wada W, et al. Transient silencing of galectin-3 expression promotes both in vitro and in vivo drug-induced apoptosis of human pancreatic carcinoma cell. Clin Exp Metastasis 2011; 28: 367\u201376.","journal-title":"Clin Exp Metastasis"},{"key":"BFaps2012150_CR6","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1053\/j.gastro.2009.09.061","volume":"138","author":"SJ Kim","year":"2010","unstructured":"Kim SJ, Choi IJ, Cheong TC, Lee SJ, Lotan R, Park SH, et al. Galectin-3 increase gastric cancer cell motility by up-regulating fascin-1 expression. Gastroenterology 2010; 138: 1035\u201345.","journal-title":"Gastroenterology"},{"key":"BFaps2012150_CR7","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.2353\/ajpath.2009.080816","volume":"174","author":"Y Wang","year":"2009","unstructured":"Wang Y, Nangia-Makker P, Tait L, Balan V, Hogan V, Pienta KJ, et al. Regulation of prostate cancer progression by galectin-3. Am J Pathol 2009; 174: 1515\u201323.","journal-title":"Am J Pathol"},{"key":"BFaps2012150_CR8","first-page":"2289","volume":"27","author":"K Tsuboi","year":"2007","unstructured":"Tsuboi K, Shimura T, Masuda N, Ide M, Tsutsumi S, Yamaguchi S, et al. Galectin-3 expression in colorectal cancer: relation to invasion and metastasis. Anticancer Res 2007; 27 (4B): 2289\u201396.","journal-title":"Anticancer Res"},{"key":"BFaps2012150_CR9","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1002\/ijc.25946","volume":"129","author":"T Kobayashi","year":"2011","unstructured":"Kobayashi T, Shimura T, Yajima T, Kubo N, Araki K, Tsutsumi S, et al. Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of beta-catenin. Int J Cancer 2011; 129: 2775\u201386.","journal-title":"Int J Cancer"},{"key":"BFaps2012150_CR10","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1080\/07357900701837051","volume":"26","author":"MA Mayoral","year":"2008","unstructured":"Mayoral MA, Mayoral C, Meneses A, Villalvazo L, Guzman A, Espinosa B, et al. Identification of galectin-3 and mucin-type O-glycans in breast cancer and its metastasis to brain. Cancer Invest 2008; 26: 615\u201323.","journal-title":"Cancer Invest"},{"key":"BFaps2012150_CR11","first-page":"4635","volume":"6","author":"Y Honjo","year":"2000","unstructured":"Honjo Y, Inohara H, Akahani S, Yoshii T, Takenaka Y, Yoshida J, et al. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin Cancer Res 2000; 6: 4635\u201340.","journal-title":"Clin Cancer Res"},{"key":"BFaps2012150_CR12","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.prp.2011.02.004","volume":"207","author":"PM Alves","year":"2011","unstructured":"Alves PM, Godoy GP, Gomes DQ, Medeiros AM, de Souza LB, da Silveira EJ, et al. Significance of galectins-1, -3, -4, and -7 in the progression of squamous cell carcinoma of the tongue. Pathol Res Pract 2011; 207: 236\u201340.","journal-title":"Pathol Res Pract"},{"key":"BFaps2012150_CR13","doi-asserted-by":"publisher","first-page":"784","DOI":"10.2741\/3957","volume":"17","author":"N Amin","year":"2012","unstructured":"Amin N, Vincan E . The Wnt signaling pathways and cell adhesion. Front Biosci 2012; 17: 784\u2013804.","journal-title":"Front Biosci"},{"key":"BFaps2012150_CR14","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.mehy.2007.01.069","volume":"69","author":"Z Wang","year":"2007","unstructured":"Wang Z, Ma Q . Beta-catenin is a promising key factor in the SDF-1\/CXCR4 axis on metastasis of pancreatic cancer. Med Hypotheses 2007; 69: 816\u201320.","journal-title":"Med Hypotheses"},{"key":"BFaps2012150_CR15","doi-asserted-by":"publisher","first-page":"e28264","DOI":"10.1371\/journal.pone.0028264","volume":"6","author":"S Bian","year":"2011","unstructured":"Bian S, Bai JP, Chapin H, Le Moellic C, Dong H, Caplan M, et al. Interactions between \u03b2-catenin and the HSIo potassium channel regulates HSIo surface expression. PLoS One 2011; 6: e28264.","journal-title":"PLoS One"},{"key":"BFaps2012150_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1593\/neo.101172","volume":"13","author":"U Stein","year":"2011","unstructured":"Stein U, Arlt F, Smith J, Sack U, Herrmann P, Walther W, et al. Intervening in beta-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis. Neoplasia 2011; 13: 131\u201344.","journal-title":"Neoplasia"},{"key":"BFaps2012150_CR17","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3892\/ijo_00000761","volume":"37","author":"S Iwai","year":"2010","unstructured":"Iwai S, Yonekawa A, Harada C, Hamada M, Katagiri W, Nakazawa M, et al. Involvement of the Wnt-beta-catenin pathway in invasion and migration of oral squamous carcinoma cells. Int J Oncol 2010; 37: 1095\u2013103.","journal-title":"Int J Oncol"},{"key":"BFaps2012150_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3892\/or.2011.1586","volume":"27","author":"B Wu","year":"2012","unstructured":"Wu B, Hu K, Li S, Zhu J, Gu L, Shen H, et al. Dihydroartiminisin inhibits the growth and metastasis of epithelial ovarian cancer. Oncol Rep 2012; 27: 101\u20138.","journal-title":"Oncol Rep"},{"key":"BFaps2012150_CR19","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3892\/or.2012.1890","volume":"28","author":"B Wu","year":"2012","unstructured":"Wu B, Li S, Sheng L, Zhu J, Gu L, Shen H, et al. Metformin inhibits the development and metastasis of ovarian cancer. Oncol Rep 2012; 28: 903\u20138.","journal-title":"Oncol Rep"},{"key":"BFaps2012150_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.5999\/aps.2012.39.2.106","volume":"39","author":"HS Shin","year":"2012","unstructured":"Shin HS, Oh HY . The effect of platelet-rich plasma on wounds of OLETF rats using expression of matrix metalloproteinase-2 and -9 mRNA. Arch Plast Surg 2012; 39: 106\u201312.","journal-title":"Arch Plast Surg"},{"key":"BFaps2012150_CR21","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s10585-011-9406-8","volume":"28","author":"SJ Kim","year":"2011","unstructured":"Kim SJ, Shin JY, Cheong TC, Choi IJ, Lee YS, Park SH, et al. Galectin-3 gemline variant at position 191 enhances nuclear accumulation and activation of \u03b2-catenin in gastric cancer. Clin Exp Metastasis 2011; 28: 743\u201350.","journal-title":"Clin Exp Metastasis"},{"key":"BFaps2012150_CR22","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/ijc.22848","volume":"121","author":"Y Shi","year":"2007","unstructured":"Shi Y, He B, Kuchenbecker KM, You L, Xu Z, Mikami I, et al. Inhibition of Wnt-1 and galectin-3 synergistically destabilizes beta-catenin and induces apoptosis in human colorectal cancer cells. Int J Cancer 2007; 121: 1175\u201381.","journal-title":"Int J Cancer"},{"key":"BFaps2012150_CR23","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1016\/j.canep.2011.11.002","volume":"36","author":"Y Song","year":"2012","unstructured":"Song Y, Yang QX, Zhang F, Meng F, Li H, Dong Y, et al. Suppression of nasopharyngeal carcinoma cell by targeting \u03b2-catenin signaling pathway. Cancer Epidemiol 2012; 36: e116\u201321.","journal-title":"Cancer Epidemiol"},{"key":"BFaps2012150_CR24","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1097\/MLG.0b013e31817b0718","volume":"118","author":"S Saussez","year":"2008","unstructured":"Saussez S, Decaestecker C, Mahillon V, Cludts S, Capouillez A, Chevalier D, et al. Galectin-3 upregulation during tumor progression in head and neck cancer. Laryngoscope 2008; 118: 1583\u201390.","journal-title":"Laryngoscope"},{"key":"BFaps2012150_CR25","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1158\/0008-5472.CAN-05-0104","volume":"65","author":"T Shimura","year":"2005","unstructured":"Shimura T, Takenaka Y, Fukumori T, Tsutsumi S, Okada K, Hogan V, et al. Implication of galectin-3 in Wnt signaling. Cancer Res 2005; 65: 3535\u20137.","journal-title":"Cancer Res"},{"key":"BFaps2012150_CR26","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nature03319","volume":"434","author":"T Reya","year":"2005","unstructured":"Reya, T, Clevers H . Wnt signaling in stem cells and cancer. Nature 2005; 434: 843\u201350.","journal-title":"Nature"},{"issue":"6","key":"BFaps2012150_CR27","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/nm.2772","volume":"18","author":"Stephan P Tenbaum","year":"2012","unstructured":"Tenbaum SP, Ordonez-Moran P, Puig I, Chicote I, Arques O, Landolfi S, et al. \u03b2-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer. Nat Med 2012; doi: 10.1038\/nm.2772.","journal-title":"Nature Medicine"},{"key":"BFaps2012150_CR28","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1158\/0008-5472.CAN-08-4153","volume":"69","author":"S Song","year":"2009","unstructured":"Song S, Mazurek N, Liu C, Sun Y, Ding QQ, Liu K, et al. Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity. Cancer Res 2009; 69: 1343\u20139.","journal-title":"Cancer Res"},{"key":"BFaps2012150_CR29","doi-asserted-by":"publisher","first-page":"21337","DOI":"10.1074\/jbc.M608810200","volume":"282","author":"N Mazurek","year":"2007","unstructured":"Mazurek N, Sun YJ, Liu KF, Gilcrease MZ, Schober W, Nangia-Makker P, et al. Phosphorylated galectin-3 mediates tumor necrosis factor-related apoptosis-inducing ligand signaling by regulating phosphatase and tensin homologue deleted on chromosome 10 in human breast carcinoma cells. J Biol Chem 2007; 282: 21337\u201348.","journal-title":"J Biol Chem"},{"key":"BFaps2012150_CR30","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/S1499-3872(12)60161-1","volume":"11","author":"YX Xia","year":"2012","unstructured":"Xia YX, Lu L, Wu ZS, Pu LY, Sun BC, Wang XH . Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta\/beta-catenin signaling pathway in mice. Hepatobiliary Pancreat Dis Int 2012; 11: 278\u201384.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"BFaps2012150_CR31","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/bjc.2012.24","volume":"106","author":"S Maseki","year":"2012","unstructured":"Maseki S, Ijichi K, Tanaka H, Fujii M, Hasegawa Y, Ogawa T, et al. Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt\/GSK\u20133\u03b2\/snail signaling pathway. Br J Cancer 2012; 106: 1196\u2013204.","journal-title":"Br J Cancer"},{"key":"BFaps2012150_CR32","first-page":"1093","volume":"28","author":"KW Lu","year":"2008","unstructured":"Lu KW, Tsai ML, Chen JC, Hsu SC, Hsia TC, Lin MW, et al. Gypenosides inhibited invasion and migration of human tongue cancer SCC4 cells through down-regulation of NF-\u03baB and matrix metalloproteinase\u20139. Anticancer Res 2008; 28: 1093\u20139.","journal-title":"Anticancer Res"},{"key":"BFaps2012150_CR33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1600-0714.2010.00960.x","volume":"40","author":"FS Giudice","year":"2011","unstructured":"Giudice FS, Dal Vechio AM, Abrahao AC, Sperandio FF, Pinto-Junior Ddos S . Different expression patterns of pAkt, NF-\u03baB and cyclin D1 proterins during the invasion process of head and neck squamous cell carcinoma: an in vitro approach. J Oral Pathol Med 2011; 40: 405\u201311.","journal-title":"J Oral Pathol Med"},{"key":"BFaps2012150_CR34","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.oraloncology.2008.04.009","volume":"45","author":"K Hu","year":"2009","unstructured":"Hu K, Li SL, Gan YH, Wang CY, Yu GY . Epiregulin promotes migration and invasion of salivary adenoid cystic carcinoma cell line SACC\u201383 through activation of ERK and Akt. Oral Oncol 2009; 45: 156\u201363.","journal-title":"Oral Oncol"},{"key":"BFaps2012150_CR35","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/01.LAB.0000073129.62433.39","volume":"83","author":"A Hittelet","year":"2003","unstructured":"Hittelet A, Camby I, Nagy N, Leqendre H, Bronckart Y, Decaestecker C, et al. Binding sites for Lewis antigens are expressed by human colon cancer cells and negatively affect their migration. Lab Invest 2003; 83: 777\u201387.","journal-title":"Lab Invest"},{"key":"BFaps2012150_CR36","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.bbrc.2004.10.181","volume":"325","author":"C Debray","year":"2004","unstructured":"Debray C, Vereecken P, Belot N, Teillard P, Brion JP, Pandolfo M, et al. Multifaceted role of galectin-3 on human glioblastoma cell motility. Biochem Biophys Res Commun 2004; 325: 1393\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFaps2012150_CR37","first-page":"2805","volume":"31","author":"JM Sant'ana","year":"2011","unstructured":"Sant'ana JM, Chammas R, Liu FT, Nonogaki S, Cardoso SV, Loyola AM, et al. Activation of the Wnt\/Beta-catenin signaling pathway during oral carcinogenesis process is not influenced by the absence of galectin-3 in mice. Anticancer Res 2011; 31: 2805\u201311.","journal-title":"Anticancer Res"},{"key":"BFaps2012150_CR38","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.bbagen.2005.12.020","volume":"1760","author":"J Dumic","year":"2006","unstructured":"Dumic J, Dabelic S, Flogel M . Galectin-3: an open-ended story. Biochim Biophys Acta 2006; 1760: 616\u201335.","journal-title":"Biochim Biophys Acta"},{"key":"BFaps2012150_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/glycob\/cwn105","volume":"19","author":"I Eude-Le Parco","year":"2009","unstructured":"Eude-Le Parco I, Gendronneau G, Dang T, Delacour D, Thijssen VL, Edelmann W, et al. Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dessemination in mice. Glycobiology 2009; 19: 68\u201375.","journal-title":"Glycobiology"},{"key":"BFaps2012150_CR40","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.3748\/wjg.14.2023","volume":"14","author":"HB Jiang","year":"2008","unstructured":"Jiang HB, Xu M, Wang XP . Panceratic stellate cells promote proliferation and invasiveness of human pancreatic cancer cells via galectin-3. Word J Gastroenterol 2008; 14: 2023\u20138.","journal-title":"Word J Gastroenterol"},{"key":"BFaps2012150_CR41","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jconrel.2011.06.026","volume":"155","author":"SJ Kim","year":"2011","unstructured":"Kim SJ, Oh JS, Shin JY, Lee KD, Sung KW, Nam SJ, et al. Development of micro RNA-145 for therapeutic application in breast cancer. J Control Release 2011; 155: 427\u201334.","journal-title":"J Control Release"}],"updated-by":[{"DOI":"10.1038\/s41401-022-00979-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000}}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/aps2012150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/aps2012150","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/aps2012150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T06:05:47Z","timestamp":1661148347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps2012150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,29]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["BFaps2012150"],"URL":"https:\/\/doi.org\/10.1038\/aps.2012.150","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,29]]},"assertion":[{"value":"22 April 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41401-022-00979-3","URL":"https:\/\/doi.org\/10.1038\/s41401-022-00979-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}